Elemental Royalty Corporation Q1 2026 Earnings EPS Falls Short of Estimates as Stock Gains Citius Oncology Q1 2026 Earnings Wide EPS Miss Highlights PreRevenue Challenges CVKD Q1 2026 Earnings NarrowerthanExpected Loss as PreRevenue Biotech Advances Pipeline CRIS Q1 2026 Earnings Significant EPS Miss Amidst Operational Updates PACCAR Q1 2026 Earnings EPS Slightly Misses Estimates Stock Holds Steady MAZE Q1 2026 Earnings EPS Surprises to the Upside Revenue Yet to Materialize